Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy
An NIH-sponsored phase I clinical trial is underway to test a potential treatment for giant axonal neuropathy (GAN) using viral-mediated GAN gene replacement (https://clinicaltrials.gov/ct2/show/NCT02362438). This trial marks the first instance of intrathecal (IT) adeno-associated viral (AAV) gene t...
Main Authors: | Rachel M. Bailey, Diane Armao, Sahana Nagabhushan Kalburgi, Steven J. Gray |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050118300172 |
Similar Items
-
Advancing the pathologic phenotype of giant axonal neuropathy: early involvement of the ocular lens
by: Diane Armao, et al.
Published: (2019-02-01) -
Giant Axonal Neuropathy with CNS Involvement
by: J Gordon Millichap
Published: (2005-06-01) -
Giant axonal neuropathy: Clinical, radiological, and genetic features
by: Meenal Garg, et al.
Published: (2018-01-01) -
Translational Feasibility of Lumbar Puncture for Intrathecal AAV Administration
by: Christian Hinderer, et al.
Published: (2020-06-01) -
Giant Axonal Neuropathy Among Two Siblings - A Case Report
by: John Jhon. K, et al.
Published: (2001-01-01)